S5237Referred to Committee

Stop Superbugs Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-08-04
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Margaret Wood Hassan
Margaret Wood Hassan
Democrat · NH · Senator
Votes with party: 74.4% (876 recorded votes)

Full profile: /officials/H001076

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-08-04

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

Plain-English summary pending. Introduced on 2026-08-04. Check back soon — summaries are generated as bills progress through Congress.

Subjects

Health

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 5237 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 5237 To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES August 4, 2026 Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Stop Superbugs Act''. SEC. 2. FUNDING FOR ANTIBIOTIC RESISTANCE CLINICAL RESEARCH. (a) In General.--The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on-- (1) supporting rapid recruitment of clinical trial participants; (2) conducting clinical trial recruitment outreach in community settings; (3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and (4) developing patient-reported outcomes in clinical studies. (b) Authorization of Appropriations.--There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a). <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.